These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9255689)
1. High-rate atrial pacing as an innovative bridging therapy in a neonate with congenital long QT syndrome. Tanel RE; Triedman JK; Walsh EP; Epstein MR; DeLucca JM; Mayer JE; Fishberger SB; Saul JP J Cardiovasc Electrophysiol; 1997 Jul; 8(7):812-7. PubMed ID: 9255689 [TBL] [Abstract][Full Text] [Related]
2. The Jervell and Lange-Nielsen syndrome; atrial pacing combined with ß-blocker therapy, a favorable approach in young high-risk patients with long QT syndrome? Früh A; Siem G; Holmström H; Døhlen G; Haugaa KH Heart Rhythm; 2016 Nov; 13(11):2186-2192. PubMed ID: 27451284 [TBL] [Abstract][Full Text] [Related]
3. Permanent cardiac pacing in patients with the long QT syndrome. Eldar M; Griffin JC; Abbott JA; Benditt D; Bhandari A; Herre JM; Benson DW; Scheinman MM J Am Coll Cardiol; 1987 Sep; 10(3):600-7. PubMed ID: 3624666 [TBL] [Abstract][Full Text] [Related]
4. Inappropriate pacing inhibition triggered by QT prolongation due to T wave oversensing in an ICD recipient presenting with long QT syndrome. Iijima K; Chinushi M; Hasegawa K; Izumi D; Hosaka Y; Furushima H; Aizawa Y Intern Med; 2011; 50(9):1021-4. PubMed ID: 21532225 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. Kaufman ES Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908 [TBL] [Abstract][Full Text] [Related]
6. Prolonged QT interval in neonates: benign, transient, or prolonged risk of sudden death. Villain E; Levy M; Kachaner J; Garson A Am Heart J; 1992 Jul; 124(1):194-7. PubMed ID: 1352080 [TBL] [Abstract][Full Text] [Related]
7. Prolonged QT, atrioventricular block, and sudden death in the newborn: an electrophysiologic evaluation. Saoudi N; Bozio A; Kirkorian G; Atallah G; Normand J; Touboul P Eur Heart J; 1991 Jul; 12(7):838-41. PubMed ID: 1889452 [TBL] [Abstract][Full Text] [Related]
8. Device therapy in the setting of long QT syndrome. Rhodes T; Weiss R Card Electrophysiol Clin; 2015 Sep; 7(3):479-86. PubMed ID: 26304528 [TBL] [Abstract][Full Text] [Related]
9. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A; JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391 [TBL] [Abstract][Full Text] [Related]
10. Influence of epinephrine, propranolol, and atrial pacing on spatial distribution of recovery time measured by body surface mapping in congenital long QT syndrome. Shimizu W; Kamakura S; Kurita T; Suyama K; Aihara N; Shimomura K J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1102-14. PubMed ID: 9363813 [TBL] [Abstract][Full Text] [Related]
11. The value of DDD pacing in patients with an implantable cardioverter defibrillator. Geelen P; Lorga Filho A; Chauvin M; Wellens F; Brugada P Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):177-81. PubMed ID: 9121985 [TBL] [Abstract][Full Text] [Related]
12. Combined use of beta-adrenergic blocking agents and long-term cardiac pacing for patients with the long QT syndrome. Eldar M; Griffin JC; Van Hare GF; Witherell C; Bhandari A; Benditt D; Scheinman MM J Am Coll Cardiol; 1992 Oct; 20(4):830-7. PubMed ID: 1356115 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of intentional permanent atrial pacing in the long-term management of congenital long QT syndrome. Kowlgi GN; Giudicessi JR; Barake W; Bos JM; Ackerman MJ J Cardiovasc Electrophysiol; 2021 Mar; 32(3):782-789. PubMed ID: 33512040 [TBL] [Abstract][Full Text] [Related]
14. Complications of permanent cardiac pacing in patients with persistent left superior vena cava. Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508 [TBL] [Abstract][Full Text] [Related]
15. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials. Wilkoff BL; Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277 [TBL] [Abstract][Full Text] [Related]
16. Congenital long QT syndromes and Brugada syndrome: the arrhythmogenic ion channel disorders. Nemec J; Shen WK Expert Opin Pharmacother; 2001 May; 2(5):773-97. PubMed ID: 11336622 [TBL] [Abstract][Full Text] [Related]
17. Molecular biology of the long QT syndrome: impact on management. Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507 [TBL] [Abstract][Full Text] [Related]
18. Intrapericardial and retrocardial implantation of implantable cardioverter-defibrillator lead in a child with type 3 long QT syndrome. Ichikawa Y; Iwamoto M; Yanagi S; Masuda M Pediatr Cardiol; 2011 Oct; 32(7):1048-52. PubMed ID: 21818650 [TBL] [Abstract][Full Text] [Related]
19. [Congenital long QT syndrome]. Creanza M; van Dam-Koopman IM; Wilde AA; Robles de Medina EO Ned Tijdschr Geneeskd; 1997 May; 141(19):926-31. PubMed ID: 9340537 [TBL] [Abstract][Full Text] [Related]
20. Two-to-one AV block associated with the congenital long QT syndrome. Pruvot E; De Torrente A; De Ferrari GM; Schwartz PJ; Goy JJ J Cardiovasc Electrophysiol; 1999 Jan; 10(1):108-13. PubMed ID: 9930915 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]